Purolite's Praesto® Agarose-based Chromatography Resins Move Into the Commercial Manufacturing of FDA-Approved Biotherapeutics
LLANTRISANT, Wales, Nov. 21, 2019 /PRNewswire/ -- Purolite Ltd., a leading manufacturer of resin-based separation, purification and extraction technologies, today announces that its Praesto® agarose-based chromatography resin range is being utilised for the commercial manufacturing of FDA-approved biotherapeutics. Praesto resins are an integral technology used by biopharmaceutical developers for the purification of modern medicines targeting the treatment of cancer, rheumatoid arthritis, dementia and diabetes.
https://mma.prnewswire.com/media/753768/Purolite_Life_Sciences_Logo.jpg
Chris Major, Global Sales and Marketing Director for the Agarose division of Purolite Life Sciences, comments, "This is a major milestone for Purolite Life Sciences, and we are truly proud that our resin technology will be used by customers in FDA-approved commercial manufacturing processes. The adoption of our Praesto product range is a testament to our technology leadership, differentiating us from competitors with 'best in class' performance, shorter lead times, and a strong commitment to security of supply. Purolite has invested over $150 million into a global expansion program in recent years, as a continued commitment to resin innovation, including doubling the production capacity of our unique, uniform-bead jetting technology. We look forward to continuing to meet our customers' growing demand for this high-performance resin."
Purolite's latest investment to increase production capacity of its proprietary, uniform-particle-size manufacturing process comes just one year after opening one of the largest agarose-based resin manufacturing facilities in the world. Based in the UK, the facility boasts a 100,000L capacity, equivalent to 30% of annual global demand.
Logo - https://mma.prnewswire.com/media/753768/Purolite_Life_Sciences_Logo.jpg
View original content:http://www.prnewswire.com/news-releases/purolites-praesto-agarose-based-chromatography-resins-move-into-the-commercial-manufacturing-of-fda-approved-biotherapeutics-300961080.html
SOURCE Purolite Life Sciences
